Connect with Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall at BIO-Europe Nov 6-8, Munich, to discover our unique formulation and drying technology LaminarPace, new external validation of our data, and our most recent deal with a major American Biomanufacturing organization.
Ziccum’s game-changing system LaminarPace transforms delicate liquid biotherapeutics into robust bioactive dry powder, with no extreme temperatures, stress or degradation, setting it apart from all other legacy drying systems.
To discuss expanding what’s possible for your next-generation vaccines and biologics – meet Ann & Fredrik in Munich, 4-6 November.
Contact Ziccum here.
